[ad_1]
The Israel Biological Research Institute (IIBR) has completed an innovative scientific study, identifying one coronavirus neutralizing antibody, announced the country’s Ministry of Defense.
“I am proud of the Institute staff, who have made an important discovery,” Defense Secretary Naphtali Bennett said Monday after a visit to his Ness Ziona-based laboratory, the Jerusalem Post reported.
IIBR is now working to secure the patent and ensure its commercial development, he added, adding that all legal proceedings will be coordinated with the Department of Defense.
“This scientific achievement has the potential to be a breakthrough in the treatment of patients with coronavirus and is not a vaccine for widespread use,” the statement added.
Last month, IIBR announced that it had begun testing a test vaccine for COVID-19 in rodents.
Meanwhile, IIBR and the city of Yeroham announced Monday that they plan to open Israel’s first vaccine production facility, in cooperation with some of the international pharmaceutical companies, according to a spokesperson for the local authority.
A total of 16,506 cases and 258 coronavirus deaths have been reported in Israel, according to Worldometer. At the same time, 11,843 people have recovered, while active cases are 4,405. Laboratory tests in the country amount to 53,902 per 1 million inhabitants. On average, Israel has recorded 30 deaths and 1,907 cases per million inhabitants.
LITTLE GIRL: Live updates – What we need to know about the crown – Continuous update here
[ad_2]
